Alfasigma Competitors and Similar CompaniesClear all
Alfasigma's competitors and similar companies include Eolo Pharma, Emergo Therapeutics and Nuwill.
 Eolo Pharma EOLO Pharma is a company that focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e.g. type II diabetes, autoimmune, metabolic syndrome, hypertension, atherosclerosis, etc.) |  Emergo Therapeutics Emergo Therapeutics is a biopharmaceutical company specializing in developing drugs to modulate inflammatory cytokines. | |||
Founding Date | Founding Date 2015 | Founding Date 2017 | Founding Date 2017 | Founding Date 2010 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations HQ | Locations Durham, US HQ | Locations Bengaluru, IN HQ | |
Employees | Employees 2,5061% increase | Employees N/A | Employees 5 | Employees 603% increase |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 2.7m (over 6 years ago) | Latest funding round $ 12m (about 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 2.7m | Total funding raised $ 12m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Eolo Pharma
HQ
EOLO Pharma is a company that focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e.g. type II diabetes, autoimmune, metabolic syndrome, hypertension, atherosclerosis, etc.)
View companyEmergo Therapeutics
HQ
Durham, US
Employees
5
Emergo Therapeutics is a biopharmaceutical company specializing in developing drugs to modulate inflammatory cytokines.
View company
Nuwill
HQ
Bengaluru, IN
Employees
60↑ 3% increase
Nuwill is a science and innovation-driven research and development company.
View company